|
|
Title: Antiviral substances
from plant cuticular and epiciticular material
United States Patent: 7,045,159
Issued: May 16, 2006
Inventors: IIic; Nebojsa
(Highland Park, NJ); Raskin; IIya (Manalapan, NJ)
Assignee: Rutgers, The
State University of New Jersey (New Brunswick, NJ)
Appl. No.: 665036
Filed: September 19, 2000
|
|
|
Outsourcing Guide
|
Abstract
Substances having antiviral activity
against one or more human disease-causing viruses are disclosed. These
antiviral substances are obtained from the cuticular and extracuticular
layers of plants. Pharmaceutical and nutraceutical formulations comprising
the antiviral substances are also disclosed, as are methods of using such
formulations to treat viral diseases.
SUMMARY OF THE
INVENTION
In accordance with the present invention,
substances from the cuticular or epicuticular layers of plants have been
identified and are shown to possess potent antiviral activities. Also
provided are methods for obtaining these antiviral substances from the
cuticular and epicuticular material of plants. When prepared according to
the method taught, these substances have particular therapeutic
application for herpes simplex virus HIV, influenza virus and other viral
infections. In addition, the invention also provides methods for the use
of these substances in a therapeutic mode.
AS used herein, the term "cuticle" or "cuticular layer" refers to a
substantially non-cellular multi-layered structure that lies over and
merges into the outer walls of epidermal cells, as shown diagrammatically
in FIG. 3 (taken from Martin & Juniper, The Cuticle of Plants, St.
Martin's Press, New York 1970). The term "cuticular material" refers
simply to material that is obtained from any part of the cuticle.
Likewise, it is known that substances (such as waxes) are exuded from the
cuticle onto the outermost surface of the plant, forming a layer referred
to herein as the "epicuticular layer". The term "epicuticular material"
refers to material or substances obtained from this layer.
It should also be understood that the term "substance" or "agent" when
used herein in the singular is intended to encompass the plural as well.
For example, a cuticular or extracuticular antiviral substance may contain
a single substance, or it may contain a mixture of two or more substances.
According to one aspect of the present invention, an antiviral preparation
obtained from the cuticular and/or epicuticular material of plants
comprising substances soluble in an organic solvent, but not requiring
disruption of the plant cells interior to the epidermal layer, is
provided. In one embodiment, the active materials are localized externally
to the epidermis of the plant, i.e., in the cuticle or deposited onto the
surface of the plant in an "epicuticular" layer. The antiviral substances
can be found in the cuticular and epicuticular layers of different plant
parts, including but not limited to fruits, flowers, leaves, stems and
roots. In a preferred embodiment, plant parts containing these antiviral
agents are obtained from one or more readily available plant species, such
as apple, avocado, bearberry, black cherry, blueberry, cabbage, cherry,
cork oak, cucumber, eucalyptus, grape, holly, orange, pear, plum
(including Japanese plum), rhododendron, tobacco, tomato, wax palm and
willow, to name a few.
According to another aspect of the invention, a method for obtaining of an
antiviral preparation from the cuticular and epicuticular layers of
plants, is provided. The objective of the method is to obtain materials
contained in the cuticle and epicuticular layers of the plant, while
minimizing or eliminating extraction from internal plant tissues. The
method comprises the following, steps: (a) plant tissues (preferably
intact, but fruit peels also may be used) are exposed to a solvent which
solubilizes the active material located external to the epidermis of the
plant (i.e., the cuticle and epicuticular layer) under conditions that
leave the internal plant tissues substantially unaffected; (b) the solvent
is partly or completely removed, leaving behind the concentrated cuticular
and epicuticular material.
The solvent is one that is capable of solubilizing compounds from a matrix
of waxy or cuticular material, or compounds dispersed on the plant's
surface that are not washed off by rain or dew; typically these would
comprise substantially non-polar solvents. For instance, the solvent may
be selected from the group consisting of hexane, chloroform,
dichloromethane, heptane, ether, petrolether, t-butyl ether, DMSO,
long-chain alcohols, petroleum derivatives, supercritical fluids and
liquefied gases. The solvent may be removed by evaporation under vacuum,
or by filtration, precipitation or lyophilization.
In one embodiment, the concentrated cuticular and epicuticular material is
resolubilized or resuspended in a second solvent that, at the
concentrations used, is minimally toxic or nontoxic to cells in vitro or
organisms in vitro. Appropriate solvents for such purposes include
combinations of one or more of ethanol, water, polyethylene glycol, DMSO,
glycerol, phenol, and other such solvents. In another embodiment, the
antiviral material is suspended in a combination of one or more of the
above-mentioned solvents, or in a colloid, or in another medium.
According to another aspect of the present invention, a pharmaceutical
formulation comprising an antiviral substance obtained from plant
cuticular and epicuticular material is provided. The pharmaceutical
formulation of this invention is effective in the treatment of a viral
disease process, and especially useful for the treatment of Herpes Simplex
Virus Type I, influenza and or HIV infections.
According to another aspect of the present invention, a method for the
treatment of, or therapeutic intervention in, a viral disease process is
provided. The method comprises administering to a patient the above
described pharmaceutical formulation at a frequency and duration
sufficient to result in reduction or alleviation of the symptoms or cause
of the viral disease process. In a preferred embodiment, the viral disease
is caused by HSV, HIV or influenza virus.
Also provided in accordance with the present invention is a nutraceutical
formulation comprising the aforementioned antiviral substances obtained
from plant cuticular and epicuticular layers. Since the antiviral
substances of the present invention can readily be prepared front common
food species, it is contemplated herein that such substances can readily
be included with formulations of nutraceutical products which are now
commonly available and used by millions of health conscious consumers
interested in alternative approaches to health. Such nutraceutical
products, comprising the antiviral substances include for example, health
beverages, herbal drinks, elixirs, juices, or teas, powdered beverage
mixes, nutritional supplements, vitamins, additives, natural remedy
formulations, health bars, creams, balms, sprays, and the like.
DETAILED DESCRIPTION
OF THE INVENTION
The development of antiviral substances
that are safe and nontoxic to infected cells and yet inhibit the
replication of the virus by one or more means is a area of great need and
much research. Ethnobotanists, pharmacologists, and others have turned to
the natural world, and especially the plant kingdom, as a vast resource of
potentially therapeutic agents with such properties as high efficacy and
low toxicity. Advances in this area will add greatly to the limited base
of therapeutic options for treatment of viral disease processes.
In accordance with the present invention, plant-derived agents possessing
antiviral properties are provided. It has been discovered in accordance
with the present invention that agents with such desirable therapeutic
properties can be removed from the cuticular and epicuticular material
present in plants, with minimal disruption of the plant tissue internal to
the epidermis of the plant. 3. The antiviral properties of these materials
likely arises from one or more constituents which comprises one or more
constituents of plant cuticular and epicuticular materials, such as waxes,
plant wax components, cutins, terpenoids, triterpenoids, phenolics,
primary alcohols, secondary alcohols, hydrocarbons, diketones, fatty acids
and flavanoids, to name a few.
Whole plants or intact plant parts may used as a source material of the
cuticular and epicuticular material, including fruits, flowers, leaves,
roots, stems, and bark. Preferred for use in the present invention are
fruits, leaves and stems. These plant parts preferably are intact;
however, peels or rinds that are mechanically separated from fruits or
other plant parts also may serve as an economical source of cuticular and
epicuticular material, inasmuch as such peels or rinds are often discarded
as refuse in the processing of fruits and vegetables.
In one embodiment, a plant species is selected which is a readily
available agricultural or horticultural plant or crop. Examples include
but are not limited to species of plants Such as apple (Malus spp.),
pear (Pyrus spp.), grape (Vita spp), orange (Citrus
spp.), tomato (Lycopersicon esculentum), cabbage (Brassica
spp.), cucumber (Cucumis spp.), cherry, black cherry, plum, peach
and apricot (all Prunus spp.), avocado (Persea spp.),
blueberry (Vaccinium spp.) bearberry (Arctostaphylos spp.)
olive (Olea) and wax palm (Copernicia spp. or Ceroxylon
spp). Other examples include tobacco (Nicotianum spp.), cork
oak (Quercus occidentialis), eucalyptus (Eucalyptus spp.),
rhododendron (Rhodendendron spp.), holly (Ilex rotunda),
Japanese plum (Eriobotrya Japonica) and willow (Salix spp.).
Still other examples include plants of the following genera: Euphorbia,
Pedilanthus, Syagrus Cocus, Attalea, Stipa, Glyceria, Saccharum, Myrica,
Rhus, Sapium, Linum, Agave, Cannabis, Raphia, Coccus, Ligustrum, Fraxinus,
Benincasa, Ricinus, Baxus, Mesembryanthemum, Rubus and Malaleuca.
These genera, as well as certain of the genera listed before these genera,
contain species known to produce an abundance of waxy or oily cuticular
and epicuticular materials.
In one embodiment, tissues are selected which are separate from the main
agronomic feature of the plant, for example: stem and leaf tissue from the
tomato vine could be used for extraction after the tomato fruit is picked.
Alternatively, in the case of fruits and vegetables, those items which due
to damage or defect are not usable for the food or feed purpose intended
may be used for extraction in lieu of diverting first quality produce. It
is also contemplated that the plant tissues from which the antiviral
extracts are prepared may consist of a mixture tissues from one or more of
these plants in certain combinations as are useful. In addition, as
discussed above, the peels or rinds of fruit provide a useful source of
cuticular and epicuticular material. These examples are intended to
illustrate, not to limit, the invention.
In accordance with the present invention, a method for preparing antiviral
substances from cuticular and epicuticular plant materials is provided.
The method comprises exposing the plant surfaces to a solvent that
solubilizes the cuticular and epicuticular portions of the plant, while
leaving, the remaining plant tissues substantially intact, followed by
concentrating or otherwise preparing the antiviral substances for further
use.
The step of solvent exposure typically involves dipping, spraying or
otherwise briefly exposing the plant (or plant part) surface to a
substantially nonpolar solvent of a type commonly used for dissolving
waxes, lipids and similar substances found in the cuticle. An appropriate
solvent typically comprises one or more solvents selected from the group
consisting of hexane, chloroform, dichloromethane, heptane, ether,
petrolether, t-butyl ether, DMSO. Other examples of suitable solvents
include organic solvents, high molecular-weight alcohols, ethers,
petroleum derivatives, supercritical fluids, liquefied gases, and other
such solvents as are known to those skilled in the art.
The method includes an optional step of clarification. The clarification
step comprises one or more separation steps to remove insoluble material
and plant residue from the solubilized cuticular and epicuticular
material. Examples of clarification processes include but are not limited
to: gravity settling; screening;
- filtration, for example, through a bed
composed of filtration medium such as would be known to those skilled in
the art, or mixing of filtration media in bulk with the solubilized
extract and allowing the filtration bed to form as the filtration media
is separated from the solubilized extract; cross-filtration; and/or
centrifugation in either continuous or batch modes under forces large
enough to separate the debris from the solubilized extract. In another
embodiment the initial or clarification solvent is removed in order to:
(a) remove any potentially deleterious effects of the solvent; and (b)
concentrate the antiviral properties of the extracted material. Solvent
removal is accomplished by art-recognized methods, including one or more
of the following: vacuum removal, evaporation, heating, centrifugal
evaporation, rotary evaporation, vortex evaporation, lyophilization,
liquid-liquid separation, solid-liquid separation, and/or precipitation
of the material followed by separation of the precipitate and the
solvent. In one embodiment, solvent is removed via rotary evaporation.
In an embodiment preferred for large-scale preparation, removal
comprises a continuous evaporation process such as is known in the art.
In another embodiment, solvent is removed after precipitation of the
antiviral properties. Such precipitation processes are well known in the
art, and may include but are not limited to one or more of the
following: addition of a precipitant, such as a salt or a further
solvent, change in temperature, and/or change in pH. Following
precipitation, the liquid phase may be decanted, filtered, evaporated or
removed by means as are known to those skilled in the art.
Following solvent removal, the antiviral substances may be re-dissolved or
resuspended in another fluid or matrix. In one embodiment, the antiviral
substances are resolubilized in a biologically compatible medium for
activity testing. Suitable media for this purpose are those that do not in
any way interfere or reduce the activity of the antiviral properties, into
which is dissolved the antiviral substances. Appropriate media for
resolubilizing or suspending the antiviral substances include combinations
of one or more of the following: ethanol, water, polyethylene glycol, DMSO,
glycerol, phenol, and other such solvents. The antiviral substances may be
suspended in a combination of one or more of the above-mentioned media, or
in a colloid, or in another medium capable of retaining the antiviral
agents in suspension. In yet another embodiment, the antiviral preparation
is used as-is after removal of the initial solvent and formulated into a
pharmaceutical or nutraceutical composition. The antiviral may be mixed
with an appropriate bulking agent to allow convenient measurement, or
alternatively may be directly formulated into a composition. In one
embodiment, the antiviral plant material is mixed with the
lipid-containing portion or ingredients of the pharmaceutical or
nutraceutical being formulated.
One or more of the cuticular and epicuticular antiviral substances
described herein have been demonstrated active against HSV-1, HIV-1 and
influenza virus, as set forth in greater detail in the examples. These
substances may also be used as therapy against other viruses, including
but not limited to poliovirus, hepadnaviruses, other herpesviruses,
cytomegalovirus, measles virus, rhinovirus, parainfluenzavirus, vesicular
stomatitis virus (VSV), vaccinia virus (VV), encephalitis virus, and
African Swine Fever virus.
In accordance with the invention, an oral pharmaceutical formulation
effective in the treatment of a viral disease process, is provided. The
pharmaceutical formulation comprises active ingredients which include the
antiviral substances from plant Cuticular and epicuticular material. In
another embodiment, a topical pharmaceutical formulation is provided,
which comprises the plant-derived antiviral substance as a waxy material
that can readily mix with lipid-containing or lipid-based ingredients and
carriers for application as a balm, ointment, lotion, roll-on, rub, cream
or other such topical applications as are known in the art.
Pharmaceutical preparations comprising the antiviral substances are
formulated in dosage unit form for ease of administration and uniformity
of dosage. Dosage unit form, as used herein, refers to a physically
discrete unit of the pharmaceutical preparation appropriate for the
patient undergoing treatment. Each dosage should contain a quantity of the
antiviral substances calculated to produce the desired antiviral effect in
association with the selected pharmaceutical carrier. Procedures for
determining the appropriate dosage unit are well known to those skilled in
the art.
Dosage units may be proportionately increased or decreased based on the
weight of the patient. Appropriate concentrations for achieving reduction
or elimination of symptoms or viral load may be determined by dosage
concentration curve calculations, as known in the art.
Also provided in accordance with the present invention is a method for
therapeutic use of the antiviral pharmaceutical formulations of the
invention for an intervention in a viral disease process. The method of
using the antiviral formulations therapeutically comprises administering a
therapeutically effective dose comprising the antiviral pharmaceutical
formulation of the invention, at a frequence and for a duration sufficient
to reduce or alleviate symptoms of the viral disease, or to lessen viral
load. The form of administration includes injection, oral administration,
inhalation or aerosolized administration, a 'patch' or transdermal
application, a sublingual application, especially if the antiviral
formulation is in colloidal form, or a topical application. In one
embodiment, the results of the method comprise greatly reduced or
eliminated symptoms related to the viral disease process. In a preferred
embodiment, the results of the method comprise a patient who is clinically
free of the viral disease. In a more preferred embodiment, the results of
the method comprise a patient who is clinically free of the disease, and
from whom all virus has been eliminated.
Also provided in accordance with the present invention are nutraceutical
formulations comprising antiviral substances obtained from the cuticular
and epicuticular material of plants. In a preferred embodiment, the
substances are obtained from an edible plant. In another embodiment, the
substances comprises a waxy material which readily mixes with lipid based
ingredients.
Claim 1 of 12 Claims
1. A method for producing a
preparation possessing antiviral activity comprising substances obtained
from cuticular or epicuticular layers external to an epidermis of a plant or
plant part, the method comprising:
a) exposing the plant or plant part to a solvent under conditions sufficient
to solubilize materials in the cuticular and epicuticular layers of the
plant, while leaving cells and tissues internal to the epidermis
substantially unaffected;
b) obtaining a solution or suspension of plant cuticular and epicuticular
materials, thereby producing the antiviral preparation; and,
c) formulating the antiviral preparation with a pharmaceutically acceptable
carrier to form a pharmaceutical composition possessing antiviral activity
in a form selected from a tablet and a capsule,
wherein the plant or plant part is selected from the group consisting of
apple.
____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|